This was demonstrated in a mouse model of dysferlinopathy, where the overexpression of human ANO5 did not rescue the myopathy phenotype or ameliorate the sarcolemmal repair defect [40]. This evidence concerns the gene ANO5 and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.